Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Christoph

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005
[Larva migrans "saxoniae": larva migrans infection in Saxony]Andreas Herrmann, Thomas Christoph, Gunther Sebastian
Frontiers in Sports and Active Living|March 4, 2022
Chronic and Residual Effects of a Two-Week Foam Rolling Intervention on Ankle Flexibility and Dynamic BalanceThomas Christoph Seever, Joel Mason, Astrid Zech
The Journal of Urology|November 16, 2004
Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious ratsTomi Streng, Thomas Christoph, Karl-Erik Andersson
Anesthesiology|March 15, 2017
Opioid-type Respiratory Depressant Side Effects of Cebranopadol in Rats Are Limited by Its Nociceptin/Orphanin FQ Peptide Receptor Agonist ActivityKlaus Linz, Wolfgang Schröder, Stefanie Frosch, et al.
Neuroscience Letters|December 23, 2009
Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic painThomas Christoph, Jean De Vry, Thomas M Tzschentke
European Journal of Pain (London, England)|September 6, 2005
Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in miceBabette Kögel, Thomas Christoph, Wolfgang Strassburger, et al.
CNS Drugs|March 1, 2014
The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadolThomas M Tzschentke, Thomas Christoph, Babette Y Kögel
Pharmacology Research & Perspectives|December 7, 2018
Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation modelThomas Christoph, Robert Raffa, Jean De Vry, et al.
European Journal of Pharmacology|February 21, 2015
Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonismKlaus Schiene, Thomas M Tzschentke, Wolfgang Schröder, et al.
Handbook of Experimental Pharmacology|March 31, 2019
Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid ReceptorsThomas M Tzschentke, Klaus Linz, Thomas Koch, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 12, 2005
[Larva migrans "saxoniae": larva migrans infection in Saxony]Andreas Herrmann, Thomas Christoph, Gunther Sebastian
Frontiers in Sports and Active Living|March 4, 2022
Chronic and Residual Effects of a Two-Week Foam Rolling Intervention on Ankle Flexibility and Dynamic BalanceThomas Christoph Seever, Joel Mason, Astrid Zech
The Journal of Urology|November 16, 2004
Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious ratsTomi Streng, Thomas Christoph, Karl-Erik Andersson
Anesthesiology|March 15, 2017
Opioid-type Respiratory Depressant Side Effects of Cebranopadol in Rats Are Limited by Its Nociceptin/Orphanin FQ Peptide Receptor Agonist ActivityKlaus Linz, Wolfgang Schröder, Stefanie Frosch, et al.
Neuroscience Letters|December 23, 2009
Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic painThomas Christoph, Jean De Vry, Thomas M Tzschentke
European Journal of Pain (London, England)|September 6, 2005
Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in miceBabette Kögel, Thomas Christoph, Wolfgang Strassburger, et al.
CNS Drugs|March 1, 2014
The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadolThomas M Tzschentke, Thomas Christoph, Babette Y Kögel
Pharmacology Research & Perspectives|December 7, 2018
Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation modelThomas Christoph, Robert Raffa, Jean De Vry, et al.
European Journal of Pharmacology|February 21, 2015
Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and µ-opioid receptor agonismKlaus Schiene, Thomas M Tzschentke, Wolfgang Schröder, et al.
Handbook of Experimental Pharmacology|March 31, 2019
Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid ReceptorsThomas M Tzschentke, Klaus Linz, Thomas Koch, et al.
Pageof 8